Predictive value of prognostic nutritional index (PNI) in recurrent or unresectable hepatocellular carcinoma received anti-PD1 therapy

BACKGROUND: Clinical trials have shown that anti-PD1 therapy, either as a monotherapy or in combination, is effective and well-tolerated in patients with recurrent or unresectable hepatocellular carcinoma (HCC). In this study, we aimed to investigate the prognostic value of immune-nutritional biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Xindan, Wang, Jing, Kang, Xue, Bai, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463676/
https://www.ncbi.nlm.nih.gov/pubmed/37612634
http://dx.doi.org/10.1186/s12885-023-11166-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463676/
https://www.ncbi.nlm.nih.gov/pubmed/37612634
http://dx.doi.org/10.1186/s12885-023-11166-w

Ejemplares similares